CRISPR Therapeutics AG (NASDAQ:CRSP)

100.32
Delayed Data
As of Oct 15
 0.00 / 0.00%
Today’s Change
84.38
Today|||52-Week Range
220.20
-34.48%
Year-to-Date
Flowstone Opportunity Fund Buys CRISPR Therapeutics AG
Oct 19 / GuruFocus News - Paid Partner Content
3 Highly Profitable Stocks Wall Street Thinks Will Soar 39% or More
Oct 15 / MotleyFool.com - Paid Partner Content
If You Invested $5,000 in Vertex Pharmaceuticals In 2016, This Is How Much You Would Have Today
Oct 19 / MotleyFool.com - Paid Partner Content
4 Biotechs to Watch Amid Rising Prominence of Gene Therapies
Oct 14 / Zacks.com - Paid Partner Content
Vertex's (VRTX) Early Type I Diabetes Study Data Promising
Oct 19 / Zacks.com - Paid Partner Content
Why CRISPR Therapeutics Stock Is Sinking Today
Oct 13 / MotleyFool.com - Paid Partner Content
3 Beaten-Down Stocks Cathie Wood Is Buying That Wall Street Thinks Will Skyrocket
Oct 19 / MotleyFool.com - Paid Partner Content
Editas (EDIT) Focuses on Developing Gene Drug for Eye Disease
Oct 13 / Zacks.com - Paid Partner Content
2 Tricks and a Treat for Gene Therapy Investors
Oct 18 / MotleyFool.com - Paid Partner Content
3 Biotech Stocks You Can Buy and Hold for the Next Decade
Oct 13 / MotleyFool.com - Paid Partner Content
2 Gene-Editing Stocks to Have on Your Radar Right Now
Oct 17 / MotleyFool.com - Paid Partner Content
How to Invest in Biotech Stocks in a Bear Market
Oct 13 / MotleyFool.com - Paid Partner Content
2 Top Healthcare Stocks That Could Be Bought Out in 2022
Oct 16 / MotleyFool.com - Paid Partner Content
2 Beaten-Down Growth Stocks to Buy Hand Over Fist
Oct 09 / MotleyFool.com - Paid Partner Content
If You Invested $3,000 in CRISPR Therapeutics in 2018, This Is How Much You Would Have Today
Oct 16 / MotleyFool.com - Paid Partner Content
Why CRISPR Therapeutics (CRSP) Stock is Falling Today
Oct 08 / Zacks.com - Paid Partner Content
3 No-Brainer Biotech Stocks to Buy Right Now
Oct 16 / MotleyFool.com - Paid Partner Content
3 Unstoppable Stocks to Buy in October
Oct 08 / MotleyFool.com - Paid Partner Content
Why Shares of Allogene Therapeutics, Beam Therapeutics, Intellia Therapeutics, and Schrödinger Are Volatile This Week
Oct 15 / MotleyFool.com - Paid Partner Content
Why CRISPR Therapeutics Stock Fell 10.4% Last Month
Oct 07 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: CRISPR Therapeutics, Editas Medicine, Sarepta Therapeutics and Beam Therapeutics
Oct 15 / Zacks.com - Paid Partner Content